In Vivo Pharmacology Services
Translational In Vivo Pharmacology Studies
Evaluating complex physiological responses in living organisms is essential to confirming candidate efficacy and safety. WuXi Biology and Testing delivers comprehensive in vivo pharmacology studies to assess therapeutic performance, mechanism of action, and early toxicity across small molecules and biologics.
Combining deep preclinical expertise with extensive disease model platforms, our team provides the reliable data and insights needed to advance your pipeline toward clinical success across all therapeutic areas.
Preclinical Integrated Services
We combine in vitro biology, PK/PD, and early toxicology studies to generate comprehensive datasets that enable confident lead selection and successful IND filings.
Our scientific teams provide tailored drug discovery solutions across multiple therapeutic areas — including oncology, immunology, infectious disease, neuroscience, fibrosis, and cardiovascular/metabolic diseases. Leveraging advanced technology platforms and deep domain expertise, we work collaboratively to rapidly propel your programs from initial target validation through preclinical candidate selection and beyond.
Assays and Tests
In vitro assays
- Protein/enzyme activity, induction & inhibition
- Transferase assays
- Cytotoxicity with primary cell cultures
- ADC off-target screening
- In vitro genetic toxicity
In vivo toxicity
- Toxicokinetics (TK)
- Systemic & organ-specific toxicity
- Short- & long-term toxicity
- Translational dose setting
- Translational safety endpoints
Benchmark, Selection
- Animal efficacy test
- Animal models with translational relevance
- Target engagement
- PD profiling
- Biomarkers
PK/PD studies (exposure–response to support efficacy)
Mechanistic Pharmacology
- Gene expression profiling (NanoString)
- Systems biology studies
- Mechanism-of-action (MoA) and disease pathway studies
Benchmark, Selection
PK
- Standard PK
- PK parameters for efficacy
- Dosing regimen design
ADME
- Stability testing
- Plasma protein binding
- Transporter studies
- Tissue distribution
- Metabolite ID
- Excretion analysis
Specialized In Vivo Pharmacology Capabilities
Explore our comprehensive collection of translational in vivo disease models across 10 key therapeutic areas to support candidate selection and IND-enabling studies.
Oncology Models
Learn More
Autoimmune and Inflammatory Disease
Learn More
Neuroscience
Learn More
Metabolic Disease
Learn More
Respiratory Disease
Learn More
Infectious Disease
Learn More
Cardiovascular Disease
Learn More
Hepatobiliary and Renal Disease
Learn More
Reproductive Disease
Learn More
Rare Disease
Learn More
Large Animal Pharmacology
Learn More
In Vivo Pharmacology Webinars & More
Rare Disease Therapeutics: Accelerating Development and Improving Access
Trends in Rare Disease Drug Development
Translational Pharmacology of CNS and Metabolic Disorders for Testing New Modality Therapies
Explore Solutions for Your Program
Explore solutions by development phase, drug modality, therapeutic area, or integrated discovery needs.
Get a Quote
Ready to plan your next study? Share your program needs with our team for a tailored estimate.



